Crossmark

Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model

Crossref DOI link: https://doi.org/10.1186/s11689-017-9215-8

Published Online: 2017-12-28

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dai, Heng

Jackson, Chad R.

Davis, Gwynne L.

Blakely, Randy D.

McMahon, Douglas G. http://orcid.org/0000-0002-0645-2281
Funding

Funding for this research was provided by:

National Institutes of Health (MH105094, MH107132, GM117650)
License Information

Text and Data Mining valid from 2017-12-01

Version of Record valid from 2017-12-28
More Information

Article History

Received: 19 June 2017

Accepted: 14 September 2017

First Online: 28 December 2017

Ethics approval

: All animal protocols were approved and in accordance with the guidelines established by the Vanderbilt University Animal Care Division and the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below